web analytics
4.7 C
Munich
Tuesday, November 29, 2022

The Buzz on Auxly Cannabis Group Inc (OTCMKTS: CBWTF)

Auxly Cannabis Group Inc (OTCMKTS: CBWTF) is considered by many to be the most exciting cannabis stock that you have never heard of. While Auxly is one of the biggest cannabis producers in the world that has not seen the type of recognition of  many of its peers.

Cannabis is booming; according to a recent report from Arcview Market Research and its research partner BDS Analytics, over the next 10 years, the legal cannabis industry will see much progress around the globe and spending on legal cannabis worldwide is expected to hit $57 billion by 2027. The adult-use (recreational) market will cover 67% of the spending; medical marijuana will take up the remaining 33%. The largest group of cannabis buyers will be in North America, going from $9.2 billion in 2017 to $47.3 billion a decade later. Of course much of this hinges on how laws progress

Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) is the world’s first-ever cannabis streaming Company that is sitting on a war chest of $295 million. The Company holds contractual rights and equity interest relating to the operation of medical cannabis facilities across Canada and provides alternative financing solutions for smaller licensed producers.

Auxly is the brainchild of Chuck Rifici – ‘Godfather of Canadian weed’ founder of Canopy Growth, former CEO of Tweed Marijuana Inc, and former CFO of the Liberal Party of Canada. Chuck did a great AMA recently on reddit you can find it here. Auxly currently has licensing and streaming deals with at least 15 licensed producers listed here. Looking at the production numbers Auxly is well on their way to being one of the biggest cannabis producers on the planet.

Auxly is also positioning itself to become a leader in the booming CBD market! they hold an 80% stake in Montevideo, Uruguay based Inverell, a federally licensed “Cannabis Operator” for the large-scale outdoor production of hemp plants for CBD extraction. Inverell has 16 hectares of plants in the ground with expansion capacity for an additional 574 hectares. Inverell gives Auxly a diversified source of low-cost CBD production for the Company’s international distribution channels. It also gives Auxly a foothold in the Uruguays cannabis market which aims to be a dominate player globally.

Chuck Rifici recently commented “Uruguay wants to be a cannabis leader so I’m really excited about the long term prospects for Uruguay as a center for production of all cannabanoids at incredibly low cost for export internationally. I think that will be a key piece of our platform as the years unfold.” In big news on the CBD front the United States Justice Department, through its Drug Enforcement Administration Agency issued a final order removing cannabidiol from their Schedule 1 list of illegal drugs on September 28.

Earlier this year Auxly acquired Dosecann Inc. a late-stage “Licensed Dealer” applicant pursuant to the Narcotic Control Regulations. Located in the biotech hub of Charlottetown, Prince Edward Island, Dosecann is currently completing the buildout of a 42,000 square foot facility, purpose-built for the research, development, extraction, formulation, filling and packaging of cannabis-based products. Dosecann plans to develop a range of value added cannabis-based products for the Company and its streaming partners to ultimately be sold to medical cannabis patients and, upon approval, into the natural health product and adult-use cannabis markets.

Auxly recently completed a strategic investment and commercial rights agreement with Kaneh Bosm. The Transaction provides Auxly access to a significant and established portfolio of international cannabis licenses, assets and distribution networks. As a result of the Transaction, Auxley believes that it has substantially accelerated its entry into numerous international cannabis markets and partnered with an ambitious team focused on future growth. As part of the transaction, Kaneh Bosm changed its name to ICC International Cannabis Corp. Kaneh Bosm has agreements in place to supply a European-based pharmaceutical distributor with a network of 35,000 pharmacies in 16 countries, in addition to working interests in industrial hemp licenses in Greece and wholly-owned licenses to cultivate, produce, distribute, store, and export cannabis in Colombia, the Kingdom of Lesotho, and Denmark.

To Find out the inside Scoop on Auxly Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

Auxly has been promoted by MarijuanaStox who claims in their disclaimer “This Advertorial was paid for by Auxly Cannabis Group Inc in an effort to enhance public awareness of Auxly Cannabis Group Inc and its securities. Winning Media has or expects to receive five hundred and fifty thousand dollars by Auxly Cannabis Group Inc Auxly Cannabis Group Inc as a total production budget for this advertising effort.

According to the report. “Auxly Cannabis Group: A Vertically-Integrated Cannabis Company with High Upside Potential: While the streaming aspect of Auxly Cannabis Group’s business is a large part of what separates the company from others in the space, Auxly Cannabis Group has evolved into a vertically-integrated cannabis company with…

* Upstream production – With 16 partners the company has a diversified cultivation platform across Canada. Plus, the company’s recent acquisition of Inverell S.A. – a licensed hemp cultivator in Uruguay – brings large-scale, low-cost CBD production as the company looks to expand globally.

* Mid-stream value add – Auxly Cannabis Group recently announced the acquisition of Dosecann Inc. – a late-stage “Licensed Dealer” with a wide array of value-enhancing intellectual property-related activities such as extraction, processing, branding and licensing, product development and manufacturing and research. Dosecann will now begin developing a range of value added cannabis-based products for Auxly Cannabis Group.

In a recent interview Chuck Rifici was asked about a possible US expansion and he stated “We would love to start making investments in the US because of the team that we built. Particularly, Hugo, MIke Lickver and others that acted for so many cannabis companies when they were running what was the largest cannabis legal practice in the world they got exposure to a lot of US companies, so we see a lot of deal flow is what I’m trying to say in the US and opportunities that we just cannot touch. So its a little painful, but at the same time the TSX Venture where we are and the TSX itself doesn’t permit us to invest in US companies so that combined with the tremendous opportunities that we have here in Canada and Internationally there is pleny for us to do here but from an investment perspective there are some great low hanging fruit, great US companies that we see listing on the CSE at much lower market valuations. To go back to your question; if it were legalized in the US we would immediately be looking at opportunities in the US and looking to essentially take our model south of the boarder and I’m sure we will do that when it happens.”

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $490 million market valuation Auxly is sitting on a war chest of $295 million, and is debt free. Led by cannabis visionary Chuck Rifici, Auxly has quickly attracted a leadership team of industry first movers, enterprising visionaries and deep-experience specialists. Auxly has licensing and streaming deals in place with at least 15 licensed producers and is well on their way to being one of the biggest cannabis producers on the planet. We will be updating on Auxly when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with Auxly.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in Auxly either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.